Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection

AIDS

Volumn 13, Issue 11, 1999, Pages 1295-1303

  Andersson, Jan ^a   Behbahani, Homira ^a,b   Lieberman, Judy ^a,b,c,d,e   Connick, Elizabeth ^a,b,c,f   Landay, Alan ^a,b,c,d,e   Patterson, Bruce ^a,b,c,d   Sönnerborg, Anders ^a,b   Lore, Karin ^a,b,c,d   Uccini, Stefania ^a,b,c   Fehniger, Thomas E ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

CTL; Cytotoxicity; Granzyme A; HIV; Lymphoid tissue; Perforin

Indexed keywords

CD8 ANTIGEN; GRANZYME A; PERFORIN;

ARTICLE; CELL GRANULE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMAGING; IMMUNOHISTOCHEMISTRY; LYMPHOID TISSUE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROCONVERSION; T LYMPHOCYTE; VIRUS REPLICATION;

CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CYTOPLASMIC GRANULES; GRANZYMES; HIV INFECTIONS; HIV-1; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHOID TISSUE; MEMBRANE GLYCOPROTEINS; PORE FORMING CYTOTOXIC PROTEINS; RNA, VIRAL; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES, CYTOTOXIC; TONSIL;

EID: 0032842111     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199907300-00005     Document Type: Article

References (36)

1. Musey L, Hughes J, Schacker T, et al. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection [see comments]. N EnglJMed 1997, 337:1267-1274.
2. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. I Virol 1994, 68:4650-4655.
3. Borrow P, Lewicki H, Wei X, et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus [see comments]. Nat Med 1997, 3:205-211.
4. Carmichael A, Jin X, Sissons P, Borysiewicz L. Quantitative analysis of the human immunodeficiency virus type 1 (HIV1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein- Barr virus in late disease. ] Exp Med 1993, 177:249-256.
5. Pantaleo C, Soudeyns H, Demarest JF, et al. Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection. Proc Natl Acad Sei USA 1997,94:9848-9853.
6. Creenough TC, Brettler DB, Somasundaran M, Panicali DL, Sullivan JL. Human immunodeficiency virus type 1-specific cylotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo. I Infect Dis 1997, 176:118-125.
7. Trimble LA, Lieberman J. Circulating CDS T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3 zeta, the signaling chain of the T-cell receptor complex. Blood 1998, 91:585-594.
8. Bouscarat F, Levacher-Clergeot M, Dazza MC, et al. Correlation of CDS lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1996, 12:17-24.
9. Ogg CS, Jin X, Bonhoeffer S, et al. Quantitation of HIV-1-specific cytoloxic T lymphocytes and plasma load of viral RNA. Science 1998, 279:2103-2106.
10. Tenner-Racz K, Racz P, Thome C, et al. Cytotoxic effector cell granules recognized by the monoclonal antibody TIA-1 are present in CD8+ lymphocytes in lymph nodes of human immunodeficiency virus-1 -infected patients. Am ] Palhol 1993, 142:1750-1758.
11. Löwin B, Mattman C, Hahne M, Tschopp J. Comparison of Fas(Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes. Inl Immunol 1996, 8:57-63.
12. Löwin B, Hahne M, Mattmann C, Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 1994, 370:650-652.
13. Wagner L, Yang OO, Carcia-Zepeda EA, et al. Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature 1998, 391:908-911.
14. Mackewicz CE, Blackbourn DJ, Levy JA. CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc Natl Acad Sei USA 1995, 92:2308-2312.
15. Cray CM, Lawrence J, Schapiro JM, el aJ. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). ) Immunol 1999, 162:1780-1788.
16. Riviere Y, McChesney MB, Porrot F, et al. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. AIDS Res Hum Retroviruses 1995, 11:903-907.
17. Moss PA, Rowland-Jones SL, Frodsham PM, et al. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc Natl Acad Sei USA 1995, 92:5773-5777.
18. VValsh CM, Matloubian M, Liu CC, et al. Immune function in mice lacking the perforin gene. Proc Natl Acad Sei USA 1994, 91:10854-10858.
19. Balla-Jhagjhoorsingh SS, Koopman C, Mooij P, el aJ. Conserved CTL epitopes shared between HIV-infected human long-term survivors and chimpanzees. S Immunol 1999, 162:2308-2314.
20. Smyth M), Trapani JA. The relative role of lymphocyte granule exocytosis versus death receptor-mediated cytotoxicity in viral pathophysiology. 1 Virol 1998, 72:1-9.
21. Spaeny-Dekking EH, Hanna VVL, VVolbink AM, et al. Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo. ] Immunol 1998, 160:3610-3616.
22. Finzi D, Hermankova M, Pierson T, et al. Identification of a reservoir for H1V-1 in patients on highly active antiretroviral therapy [see comments]. Science 1997, 278:1295-1300.
23. Andersson J, Fehniger TE, Patterson BK, et al. Early reduction of immune activation in lymphoid tissue following highly active HIV therapy. AIDS 1998, 12:F123-F129.
24. Beresford PJ, Kam CM, Powers JC, Lieberman J. Recombinant human granzyme A binds to two putative HLA-associated proteins and cleaves one of them. Proc Natl Acad Sei USA 1997, 94:9285-9290.
25. Bjork L, Tracey KJ, Ulrich P, et al. Targeted suppression of cytokine production in monocytes but not in T lymphocytes by a tetravalent guanylhydrazone (CNI-1493,). J Infect Dis 1997, 176:1303-1312.
26. Bjork L, Fehniger TE, Andersson U, Andersson J. Computerized assessment of production of multiple human cytokines at the single-cell level using image analysis. I Leukocyte Biol 1996, 59:287-295.
27. Centers for Disease Control and Prevention. Classification for lymphotropic virus type Ill/lymph adenopathy associated virus infections. MMVVR 1986; 35:334-339.
28. Cavert W, Notermans DVV, Staskus K, et al. Kinetics of response in lymphoid tissues to antirelroviral therapy of HIV-1 infection [see comments). Science 1997, 276:960-964. [Published erratum appears in Science 1997, 276:1321.]
29. Bochan M, Hommel-Berrey G, Brahmi Z. Target cell-directed degradation of perforin mRNA in CTL: lack of correlation with loss of protein and lytic ability. Mol Immunol 1994, 31:401-410.
30. Rukavina D, Laskarin G, Rubesa G, et al. Age-related decline of perforin expression in human cytotoxic T lymphocytes and natural killer cells. Blood 1998, 92:2410-2420.
31. Jans DA, Briggs LJ, Jans P, et al. Nuclear targeting of the serine protease granzyme A (fragmentin-1). ] Cell Sei 1998, 111:2645-2654.
32. Shi L, Mai S, Israels S, Browne K, Trapani JA, Creenberg.AH. Cranzyme B (GraB) autonomously crosses the cell membrane and perforin initiates apoptosis and GraB nuclear localization.; Exp Med 1997, 185:855-866.
33. Saukkonen J), Kornfeld H, Berman JS. Expansion of a CD8+CD28- cell population in the blood and lung of HIVpositive patients. I Acquir Immune Defic Syndr 1993, 6:1194-1204.
34. Mollet L, Sadat-Sowti B, Duntze J, et al. CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity. Int Immunol 1998, 10:311-323.
35. Borthwick NJ, Bofill M, Combert WM, et al. Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells. AIDS 1994, 8:431-441.
36. Wolthers KC, Otto SA, Lens SM, et al. Functional B cell abnormalities in HIV type 1 infection: role of CD40L and CD70. AIDSRes Hum Retroviruses 1997, 13:1023-1029.